- Home
- HOOK vs TURN Comparison
HOOK vs TURN Comparison
Compare HOOK & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- TURN
- Stock Information
- Founded
- HOOK 2011
- TURN 1981
- Country
- HOOK United States
- TURN United States
- Employees
- HOOK N/A
- TURN N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- HOOK Health Care
- TURN Finance
- Exchange
- HOOK Nasdaq
- TURN Nasdaq
- Market Cap
- HOOK 30.2M
- TURN 33.3M
- IPO Year
- HOOK 2019
- TURN N/A
- Fundamental
- Price
- HOOK $2.80
- TURN $3.26
- Analyst Decision
- HOOK Strong Buy
- TURN
- Analyst Count
- HOOK 4
- TURN 0
- Target Price
- HOOK $38.75
- TURN N/A
- AVG Volume (30 Days)
- HOOK 53.3K
- TURN 21.5K
- Earning Date
- HOOK 11-22-2024
- TURN 11-29-2024
- Dividend Yield
- HOOK N/A
- TURN N/A
- EPS Growth
- HOOK N/A
- TURN N/A
- EPS
- HOOK N/A
- TURN N/A
- Revenue
- HOOK $49,999,000.00
- TURN $129,297.00
- Revenue This Year
- HOOK $155.36
- TURN N/A
- Revenue Next Year
- HOOK N/A
- TURN N/A
- P/E Ratio
- HOOK N/A
- TURN N/A
- Revenue Growth
- HOOK 227.80
- TURN 6.32
- 52 Week Low
- HOOK $2.76
- TURN $3.12
- 52 Week High
- HOOK $11.30
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- HOOK 21.10
- TURN 47.87
- Support Level
- HOOK $3.58
- TURN $3.23
- Resistance Level
- HOOK $3.84
- TURN $3.36
- Average True Range (ATR)
- HOOK 0.26
- TURN 0.08
- MACD
- HOOK -0.08
- TURN 0.00
- Stochastic Oscillator
- HOOK 2.96
- TURN 36.24
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.